Ready for takeoff: ARPA-H intros plan to attract project investors, commercialize products
The newly-appointed director of the Advanced Research Projects Agency for Health (ARPA-H), Renee Wegrzyn, updated the NIH Advisory Committee to the Director today on the brand-new department and her plans for hiring, attracting R&D projects and capital investments for those projects.
ARPA-H, a new NIH-housed agency that’s looking to fill R&D gaps and go a step further than the NIH to attack riskier, potentially more rewarding biomedical innovation, said it’s focusing on four main priorities to begin: accelerating advances that apply to a range of diseases; tackling supply chain and manufacturing challenges; preventative programs; and building resilient systems. President Joe Biden appointed Wegrzyn in November.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.